Summary
67 / 100 · Bulios Score
What speaks for it
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 1.7% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.2 SAR for 1 SAR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (SAR)
Diluted EPS (SAR)
- Analyst estimate
Revenue grew by 0.3% a year over 5 years. Over the last 3 years it fell by 1.7% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 SAR of revenue goes
- Cost of sales 20 SAR
- Sales and administration 70 SAR
- Taxes and other 2.1 SAR
- Net profit 8.2 SAR
Net profit, industry median (Insurance - Diversified) 8.3 SAR
Out of every 100 SAR of revenue, 8.2 SAR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail